Center for Molecular Imaging Innovation and Translation

The time has come, say medical experts from around the country, to advance medical care of prostate cancer—with molecular imaging leading the way.
“We have a prostate cancer crisis,” says Faina Shtern, M.D., president and CEO of the AdMeTech Foundation. “There is an opportunity for imaging to transform patient care and end this crisis.” Read More